Can Fite Biopharma ADR Aktie Logo
US13471N3008
A3D4G4
CANF

Can Fite Biopharma ADR Aktie

Dividend yield TTM
0.00%
€0.00/unit
Dividend growth (CAGR 5Y)
-
Next dividend
It is unlikely that any further dividends will be paid.

Upcoming dividends delivered straight to your inbox

Historical dividends

In 2013, Can Fite Biopharma ADR Aktie has already paid €0.13 in dividends. The last payout was in November 2013.

Tools for dividend investors

Dividend metrics Metrics

All metrics All
Metric Value
Price
€1.92
Yield
0.00%
Interval
None
CAGR 3Y
-
CAGR 5Y
-
CAGR 10Y
-

All dividend data

Can Fite Biopharma ADR Aktie has not paid a dividend in the last 3 years. It is therefore likely that no further dividends will be paid.

New dividends delivered straight to your inbox
Ex-dividend date
Payment date
Distribution
YoY
Yield
2013 €0.13 0.00% 0.00%
11/12/2013 11/25/2013 €0.13

Frequently asked questions

When was the most recent dividend payment date for Can Fite Biopharma ADR Aktie?

The most recent payment was made on 11/25/2013.

When did you need to hold Can Fite Biopharma ADR Aktie in your portfolio to receive the latest dividend?

If you held Can Fite Biopharma ADR Aktie in your portfolio on 11/12/2013, you received the payout.

When is the next dividend from Can Fite Biopharma ADR Aktie expected?

As Can Fite Biopharma ADR Aktie has not paid a dividend in the last 3 years, it is unlikely to pay another dividend.

More dividend stocks

All dividends in the calendar
Name Interval
Yield
CAGR 5Y
PVA TePla Logo
DE0007461006
746100
- 0.00% -
Schlumberger Logo
AN8068571086
853390
Q 2.03% 2.02%
Clorox Logo
US1890541097
856678
Q 5.23% 2.79%
Brenntag Logo
DE000A1DAHH0
A1DAHH
Y 3.10% 10.93%
Münchener Rück Logo
DE0008430026
843002
Y 4.53% 15.33%
Moody's Logo
US6153691059
915246
Q 0.78% 11.14%
Banco Bilbao Vizcaya Argentaria Logo
ES0113211835
875773
H 3.60% 35.47%
Hamborner REIT Logo
DE000A3H2333
A3H233
Y 9.07% 0.42%
Verisign Logo
US92343E1029
911090
Q 1.09% -
PetMed Express Logo
US7163821066
121843
- 0.00% -
🍪

Parqet  uses cookies. Learn more